Exploring beyond Common Cell Death Pathways in Oral Cancer: A Systematic Review

Leonardo de Oliveira Siquara da Rocha1,2, Everton Freitas de Morais3, Lilianny Querino Rocha de Oliveira3

  • 1Department of Pathology and Forensic Medicine, School of Medicine, Federal University of Bahia, Salvador 40110-100, BA, Brazil.

Biology
|February 23, 2024
PubMed

Insights

Novel cell death pathways like ferroptosis, pyroptosis, and necroptosis offer new therapeutic strategies for oral squamous cell carcinoma (OSCC). Understanding these mechanisms can improve diagnosis, prognosis, and individualized treatment for OSCC patients.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • Oral squamous cell carcinoma (OSCC) is a globally prevalent and deadly cancer.
  • Existing therapies for OSCC often face variable responses and resistance, necessitating novel treatment strategies.
  • Recent advancements have deepened the understanding of programmed cell death mechanisms.

Purpose of the Study:

  • To systematically review emerging programmed cell death pathways in OSCC.
  • To highlight the diagnostic, prognostic, and therapeutic potential of these cell death forms.
  • To explore how these pathways can inform individualized OSCC treatment.

Main Methods:

  • Systematic literature review of original studies on selected cell deaths in OSCC.
  • Searches conducted across four databases.
  • Data extraction, categorization by cell death type, and risk of bias assessment.

Main Results:

  • Ferroptosis, pyroptosis, and necroptosis were the most frequently studied cell death types in OSCC.
  • These pathways are linked to cancer immunity, inflammation, OSCC progression, and prognosis.
  • The review synthesized data from 79 articles.

Conclusions:

  • Emerging cell death pathways present promising therapeutic targets for OSCC.
  • Harnessing these pathways can aid in patient-specific prognosis and personalized therapy.
  • Integration of these cell death types may lead to improved diagnostic and therapeutic decision tools for OSCC.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K